(Q37990759)

26 August 2017

title

Glucose metabolism in patients with subclinical Cushing's syndrome (English)

1 reference

26 August 2017

0 references

9

Emanuela Arvat

1 reference

26 August 2017

Roberta Giordano

1

1 reference

26 August 2017

Federica Guaraldi

2

1 reference

26 August 2017

Rita Berardelli

3

1 reference

26 August 2017

Ioannis Karamouzis

4

1 reference

26 August 2017

Valentina D'Angelo

5

1 reference

26 August 2017

Elisa Marinazzo

6

1 reference

26 August 2017

Andreea Picu

7

1 reference

26 August 2017

Ezio Ghigo

8

1 reference

26 August 2017

publication date

6 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

41

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

415-423

1 reference

Subclinical Cushing's syndrome

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Clinical review: Diagnosis and treatment of subclinical hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Glucocorticoid receptor variants: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Glucocorticoids and insulin resistance: old hormones, new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Feast and famine: critical role of glucocorticoids with insulin in daily energy flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Glucocorticoid-induced osteoporosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Incidentalomas. A disease of modern technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Management of the clinically inapparent adrenal mass ("incidentaloma")

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

The clinically inapparent adrenal mass: update in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Clinical practice. The incidentally discovered adrenal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Approach to the Patient with an Adrenal Incidentaloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

AME position statement on adrenal incidentaloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Adrenal incidentaloma: a new cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Prevalence of Subclinical Cushing's Syndrome in 70 Patients with Adrenal Incidentaloma: Clinical, Biochemical and Surgical Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

46,XY disorders of sex development (DSD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Adrenal incidentalomas: a manifestation of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

"Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Occult Cushing's syndrome in type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Screening for subclinical Cushing's syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Is there value in routine screening for Cushing's syndrome in patients with diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Subclinical Cushing's syndrome in adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9628-9

[Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients]

21 January 2018

1 reference

12 December 2020

Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features

1 reference

12 December 2020

A-I-D-S: the new endocrine epidemic

1 reference

12 December 2020

Hypercortisolism in diabetes mellitus

1 reference

12 December 2020

Diabetes in Cushing syndrome: basic and clinical aspects

1 reference

12 December 2020

Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus

1 reference

12 December 2020

A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

1 reference

12 December 2020

Incidentally discovered adrenal masses

1 reference

12 December 2020

Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids

1 reference

12 December 2020

Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients

1 reference

12 December 2020

Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study

1 reference

12 December 2020

Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects.

1 reference

12 December 2020

Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat

1 reference

12 December 2020

Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

1 reference

12 December 2020

The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas

1 reference

12 December 2020

Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

Cushing's syndrome in a clinic population with diabetes

1 reference

12 December 2020

10.1007/S12020-012-9628-9

Identifiers

DOI

1 reference

26 August 2017

1 reference